What is Aurinia Pharmaceuticals Inc's Market Cap?

Aurinia Pharmaceuticals Inc's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's Enterprise Value?

Aurinia Pharmaceuticals Inc's Enterprise Value is $2.0B, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's Trailing P/E?

Aurinia Pharmaceuticals Inc's Trailing P/E is 6.8×, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's Price / Sales?

Aurinia Pharmaceuticals Inc's Price / Sales is 6.9×, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's EV / Revenue?

Aurinia Pharmaceuticals Inc's EV / Revenue is 6.5×, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's EV / EBITDA?

Aurinia Pharmaceuticals Inc's EV / EBITDA is 11.9×, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's Revenue (TTM)?

Aurinia Pharmaceuticals Inc's Revenue (TTM) is $311.5M, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's Net Income (TTM)?

Aurinia Pharmaceuticals Inc's Net Income (TTM) is $314.1M, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's EBITDA?

Aurinia Pharmaceuticals Inc's EBITDA is $170.1M, based on as-reported figures from SEC (XBRL) filings.

What is Aurinia Pharmaceuticals Inc's Diluted EPS (TTM)?

Aurinia Pharmaceuticals Inc's Diluted EPS (TTM) is 2.36, based on as-reported figures from SEC (XBRL) filings.

Aurinia Pharmaceuticals Inc (AUPH) Financial Statements

Aurinia Pharmaceuticals Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S68013

XNAS · usd

16.17▲ 0.09 (0.59%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close16.07

Day's Range15.93 – 16.38

52-Week Range10.34 – 19.25

Volume965.5K

Avg Volume1.1M

Share Statistics

Shares Outstanding

Employees128

ExchangeXNAS

Listed2009-10-21

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Aurinia Pharmaceuticals Inc (AUPH)

What is Aurinia Pharmaceuticals Inc's Market Cap?: Aurinia Pharmaceuticals Inc's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's Enterprise Value?: Aurinia Pharmaceuticals Inc's Enterprise Value is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's Trailing P/E?: Aurinia Pharmaceuticals Inc's Trailing P/E is 6.8×, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's Price / Sales?: Aurinia Pharmaceuticals Inc's Price / Sales is 6.9×, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's EV / Revenue?: Aurinia Pharmaceuticals Inc's EV / Revenue is 6.5×, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's EV / EBITDA?: Aurinia Pharmaceuticals Inc's EV / EBITDA is 11.9×, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's Revenue (TTM)?: Aurinia Pharmaceuticals Inc's Revenue (TTM) is $311.5M, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's Net Income (TTM)?: Aurinia Pharmaceuticals Inc's Net Income (TTM) is $314.1M, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's EBITDA?: Aurinia Pharmaceuticals Inc's EBITDA is $170.1M, based on as-reported figures from SEC (XBRL) filings.
What is Aurinia Pharmaceuticals Inc's Diluted EPS (TTM)?: Aurinia Pharmaceuticals Inc's Diluted EPS (TTM) is 2.36, based on as-reported figures from SEC (XBRL) filings.